Phase 2 Type 1 Diabetes Trial, Recruiting (NCT04933851)

Phase 2 Type 1 Diabetes Trial, Recruiting NCT04933851 Sponsor: Scripps Whittier Diabetes Institute Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT04933851 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You speak Spanish or English
You have been diagnosed with Type 1 diabetes
Your recent blood sugar control test (called HbA1c), taken within the last 90 days, showed a result between 7.0% and 12.5%
You have screened positive for diabetes distress, meaning you are experiencing significant emotional or mental stress related to managing your diabetes

Who may not be able to join:

You have a serious medical or mental health condition that a healthcare provider believes would make it difficult for you to take part in the trial
You are planning to move away from the San Diego area within the next 12 months
You do not have access to the technology needed, such as a device and internet connection, to complete online surveys and attend virtual medical appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Addie Fortmann, PhD, Scripps Whittier Diabetes Institute

Phone: 970-497-6701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04933851

Sponsor: Scripps Whittier Diabetes Institute

Phase: Phase 2

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 970-497-6701

More information: https://clinicaltrials.gov/study/NCT04933851

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You speak Spanish or English
You have been diagnosed with Type 1 diabetes
Your recent blood sugar control test (called HbA1c), taken within the last 90 days, showed a result between 7.0% and 12.5%
You have screened positive for diabetes distress, meaning you are experiencing significant emotional or mental stress related to managing your diabetes

Who may not be able to join:

You have a serious medical or mental health condition that a healthcare provider believes would make it difficult for you to take part in the trial
You are planning to move away from the San Diego area within the next 12 months
You do not have access to the technology needed, such as a device and internet connection, to complete online surveys and attend virtual medical appointments

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Scripps Whittier Diabetes Institute

Registry

ClinicalTrials.gov

Start date

25 October 2021

Est. completion

31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Glycosylated Hemoglobin (HbA1c); Diabetes Distress Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov